Eli Lilly is closely tied to the sales of Prozac, regardless of other profits it might make.
Drug maker Eli Lilly saw its profits rise 15 percent in the most recent quarter, meeting estimates, but its shares fell nonetheless when it announced that Prozac sales were down significantly.